American Growth Fund Series Two ($AMREX) Added to The 420
Cannabis Investor Ideas Directory; #420CannabisInvestorideas.com
“This is a great time for the
industry as a whole”- Timothy Taggart, CEO of American Growth
Pt. Roberts, WA; Delta, BC - April 18, 2017 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its affiliated directory www.420cannabisinvestorideas.com announce the most recent addition; The American Growth
Fund Series Two (NASDAQ: AMREX).
The 420 Cannabis
Investor Ideas directory will feature
a maximum of 420 companies to be showcased for a year, including newsletters,
research, experts, publicly traded companies, private companies and any service
that offers insight or opportunity for investing in the sector. Investorideas.com will create a free
downloadable PDF of the full directory for investors to use as a reference and
due diligence tool at the end of the year.
American Growth Fund Series Two (NASDAQ:
AMREX), is currently the country's only
Cannabis Mutual Fund. Headquartered in
Denver, this diversified fund focuses solely on the cannabis industry. Approved by the SEC, it invests in publicly
traded companies in areas that support this exploding industry like
pharmaceuticals, agriculture, hydroponic, equipment, to name a few.
Read this release
in full at http://www.investorideas.com/news/2017/marijuana/04182AMREX.asp
Timothy Taggart is the CEO of American Growth Fund Series
Two (AMREX), currently the United States' only Cannabis Mutual Fund. Headquartered in Denver, this diversified
fund focuses solely on the cannabis industry.
Approved by the SEC, it invests in publicly traded companies in areas
that support the industry like pharmaceuticals, agriculture, hydroponic,
equipment, to name a few. He's been following recent week’s development and
says this is a great time for the industry as a whole.
“The legal cannabis
industry is on the rise and does not seem to be slowing down. As the cannabis
industry evolves we will see that some cannabis related stocks are not winners,
but several of the examples that follow are a fairly good indication as to where
the cannabis industry is headed. North American sales are projected to top
$20.2 billion by 2021 and reach up to $50 billion in the next decade. I believe
this to be true because we have seen some significant growth in several
cannabis related stocks. Some of these stocks include (OTC: OWCP) which has seen a 248% growth YTD. OWCP has a cannabis
based crème for Psoriasis. Cara
Therapeutics (NASDAQ: CARA) has seen a 103% growth YTD because
they are developing a cannabis-based pharmaceutical product that relieves
itching in pruritus patients. They are
also making headway in their medical trials with drugs related to chronic
kidneys associated with pruritus. CARA not only has a 103% growth YTD but
surged 15% in March according to the FMP globally market intelligence. Lastly,
Zynerba Pharmaceuticals Inc. (NASDAQ: ZYNE) is up 58% YTD. ZYNE has developed a CBD gel for people
with epilepsy. This gel has proven to lower incidents of seizures in patients
with epilepsy,” Taggart says.
Previous Investorideas.com interview with Timothy Taggart,
CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis
Mutual Fund in the US
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
podcasts, company profiles, interviews and more in leading sectors.
Investorideas.com cannabis/marijuana
and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer: This directory
is not a recommendation to buy or sell securities or products or services
Investorideas.com charges a fee for placement. The directory is not an
endorsement or recommendation but meant to be an investor resource/ due
diligence tool.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure:
Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of
Up to $1000 to be featured on the directory www.420cannabisinvestorideas.com
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment